The abstract is read at the publisher; the summary is JClub's.
Clair3-RNA showed the broadest, most robust small-variant calling applicability across ONT and PacBio lrRNA-seq chemistries, outperforming no single caller overall but spanning contexts.
- Why it matters: lrRNA-seq enables transcript-resolved variant detection, yet neutral, systematic comparisons across technologies, aligners, callers, genomic contexts, and phasing tools are limited.
- What they did: The study benchmarks six lrRNA-seq callers (Clair3-RNA, DeepVariant, NanoTS, isoLASER, longcallR, longcallR-nn) plus GATK HaplotypeCaller on GIAB three-cell-line datasets across four ONT and two PacBio protocols, testing alignment strategies and phasing tools (WhatsHap, LongPhase, HapCUT2, HiPhase, isoLASER, longcallR) and extending to LongBench.
- The result: Sequencing characteristics were the strongest determinant, with caller and alignment strategies next and genomic context adding effects; HiPhase/LongPhase minimized switch errors on PacBio/ONT, WhatsHap maximized coverage/contiguity, HapCUT2 balanced SNV accuracy and coverage, and longcallR supported joint calling and phasing.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.